• Return to Headlines

Downtrend Call Working As Alder Biopharmac Stock Falls 33.9% (ALDR)

By Nick Russo

SmarTrend identified a Downtrend for Alder Biopharmac (NASDAQ:ALDR) on June 27th, 2017 at $14.67. In approximately 2 months, Alder Biopharmac has returned 33.90% as of today's recent price of $9.70.

In the past 52 weeks, Alder Biopharmac share prices have been bracketed by a low of $8.60 and a high of $36.48 and are now at $9.70, 13% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 1.5% while the 50-day MA has advanced 2.1%.

Alder Biopharmaceuticals, Inc. provides pharmaceutical products and services. The Company identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Alder Biopharmac.

Log in and add Alder Biopharmac (ALDR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights alder biopharmac

Ticker(s): ALDR